Gynecologic cancer intergroup (GCIG) endometrial cancer clinical trials planning meeting: Taking endometrial cancer trials into the translational era

Carien L. Creutzberg, Henry C. Kitchener, Michael J. Birrer, Fabio Landoni, Karen H. Lu, Melanie Powell, Carol Aghajanian, Richard Edmondson, Paul J. Goodfellow, Michael Quinn, Helga B. Salvesen, Gillian Thomas

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: The second Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting was held on December 1, 2012, and included international multidisciplinary representatives of the 24 member groups. The aims were to review recent advances in molecular pathology of endometrial cancer, focusing on molecular-based therapy, and to identify key hypotheses and issues to be addressed through international collaborative clinical trials. Methods: Reviews and summaries of current knowledge were presented followed by parallelworking group sessions for surgery, adjuvant and systemic therapy, and translational research. Plenary discussions were held to integrate translational and clinical issues, and a final discussion session to agree on key trial concepts. Results and Conclusions: Proposals to take forward on the following trials were agreed: (1) lymphadenectomy to direct adjuvant treatment in women with high-risk endometrial cancer, including a sentinel node substudy; (2) conservative therapy for low-risk endometrial cancers in morbidly obese women with high surgical risks and for fertility-sparing treatment in premenopausal patients; (3) adjuvant therapy for women with early-stage carcinosarcoma. A proposal was made that a GCIG Early Phase Consortium be developed to serve as an international platform for rapid assessment of biomarkers.

Original languageEnglish
Pages (from-to)1528-1534
Number of pages7
JournalInternational Journal of Gynecological Cancer
Volume23
Issue number8
DOIs
Publication statusPublished - 2013

Fingerprint

Endometrial Neoplasms
Clinical Trials
Neoplasms
Carcinosarcoma
Therapeutics
Translational Medical Research
Second Primary Neoplasms
Molecular Pathology
Lymph Node Excision
Fertility
Biomarkers

Keywords

  • Clinical trials planning meeting
  • Endometrial cancer
  • Gynecological Cancer Intergroup
  • International collaboration
  • Randomised trials

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Gynecologic cancer intergroup (GCIG) endometrial cancer clinical trials planning meeting : Taking endometrial cancer trials into the translational era. / Creutzberg, Carien L.; Kitchener, Henry C.; Birrer, Michael J.; Landoni, Fabio; Lu, Karen H.; Powell, Melanie; Aghajanian, Carol; Edmondson, Richard; Goodfellow, Paul J.; Quinn, Michael; Salvesen, Helga B.; Thomas, Gillian.

In: International Journal of Gynecological Cancer, Vol. 23, No. 8, 2013, p. 1528-1534.

Research output: Contribution to journalArticle

Creutzberg, CL, Kitchener, HC, Birrer, MJ, Landoni, F, Lu, KH, Powell, M, Aghajanian, C, Edmondson, R, Goodfellow, PJ, Quinn, M, Salvesen, HB & Thomas, G 2013, 'Gynecologic cancer intergroup (GCIG) endometrial cancer clinical trials planning meeting: Taking endometrial cancer trials into the translational era', International Journal of Gynecological Cancer, vol. 23, no. 8, pp. 1528-1534. https://doi.org/10.1097/IGC.0b013e3182a26edb
Creutzberg, Carien L. ; Kitchener, Henry C. ; Birrer, Michael J. ; Landoni, Fabio ; Lu, Karen H. ; Powell, Melanie ; Aghajanian, Carol ; Edmondson, Richard ; Goodfellow, Paul J. ; Quinn, Michael ; Salvesen, Helga B. ; Thomas, Gillian. / Gynecologic cancer intergroup (GCIG) endometrial cancer clinical trials planning meeting : Taking endometrial cancer trials into the translational era. In: International Journal of Gynecological Cancer. 2013 ; Vol. 23, No. 8. pp. 1528-1534.
@article{1b73a409e6bd4e85a8c46578baf185d4,
title = "Gynecologic cancer intergroup (GCIG) endometrial cancer clinical trials planning meeting: Taking endometrial cancer trials into the translational era",
abstract = "Objective: The second Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting was held on December 1, 2012, and included international multidisciplinary representatives of the 24 member groups. The aims were to review recent advances in molecular pathology of endometrial cancer, focusing on molecular-based therapy, and to identify key hypotheses and issues to be addressed through international collaborative clinical trials. Methods: Reviews and summaries of current knowledge were presented followed by parallelworking group sessions for surgery, adjuvant and systemic therapy, and translational research. Plenary discussions were held to integrate translational and clinical issues, and a final discussion session to agree on key trial concepts. Results and Conclusions: Proposals to take forward on the following trials were agreed: (1) lymphadenectomy to direct adjuvant treatment in women with high-risk endometrial cancer, including a sentinel node substudy; (2) conservative therapy for low-risk endometrial cancers in morbidly obese women with high surgical risks and for fertility-sparing treatment in premenopausal patients; (3) adjuvant therapy for women with early-stage carcinosarcoma. A proposal was made that a GCIG Early Phase Consortium be developed to serve as an international platform for rapid assessment of biomarkers.",
keywords = "Clinical trials planning meeting, Endometrial cancer, Gynecological Cancer Intergroup, International collaboration, Randomised trials",
author = "Creutzberg, {Carien L.} and Kitchener, {Henry C.} and Birrer, {Michael J.} and Fabio Landoni and Lu, {Karen H.} and Melanie Powell and Carol Aghajanian and Richard Edmondson and Goodfellow, {Paul J.} and Michael Quinn and Salvesen, {Helga B.} and Gillian Thomas",
year = "2013",
doi = "10.1097/IGC.0b013e3182a26edb",
language = "English",
volume = "23",
pages = "1528--1534",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Gynecologic cancer intergroup (GCIG) endometrial cancer clinical trials planning meeting

T2 - Taking endometrial cancer trials into the translational era

AU - Creutzberg, Carien L.

AU - Kitchener, Henry C.

AU - Birrer, Michael J.

AU - Landoni, Fabio

AU - Lu, Karen H.

AU - Powell, Melanie

AU - Aghajanian, Carol

AU - Edmondson, Richard

AU - Goodfellow, Paul J.

AU - Quinn, Michael

AU - Salvesen, Helga B.

AU - Thomas, Gillian

PY - 2013

Y1 - 2013

N2 - Objective: The second Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting was held on December 1, 2012, and included international multidisciplinary representatives of the 24 member groups. The aims were to review recent advances in molecular pathology of endometrial cancer, focusing on molecular-based therapy, and to identify key hypotheses and issues to be addressed through international collaborative clinical trials. Methods: Reviews and summaries of current knowledge were presented followed by parallelworking group sessions for surgery, adjuvant and systemic therapy, and translational research. Plenary discussions were held to integrate translational and clinical issues, and a final discussion session to agree on key trial concepts. Results and Conclusions: Proposals to take forward on the following trials were agreed: (1) lymphadenectomy to direct adjuvant treatment in women with high-risk endometrial cancer, including a sentinel node substudy; (2) conservative therapy for low-risk endometrial cancers in morbidly obese women with high surgical risks and for fertility-sparing treatment in premenopausal patients; (3) adjuvant therapy for women with early-stage carcinosarcoma. A proposal was made that a GCIG Early Phase Consortium be developed to serve as an international platform for rapid assessment of biomarkers.

AB - Objective: The second Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting was held on December 1, 2012, and included international multidisciplinary representatives of the 24 member groups. The aims were to review recent advances in molecular pathology of endometrial cancer, focusing on molecular-based therapy, and to identify key hypotheses and issues to be addressed through international collaborative clinical trials. Methods: Reviews and summaries of current knowledge were presented followed by parallelworking group sessions for surgery, adjuvant and systemic therapy, and translational research. Plenary discussions were held to integrate translational and clinical issues, and a final discussion session to agree on key trial concepts. Results and Conclusions: Proposals to take forward on the following trials were agreed: (1) lymphadenectomy to direct adjuvant treatment in women with high-risk endometrial cancer, including a sentinel node substudy; (2) conservative therapy for low-risk endometrial cancers in morbidly obese women with high surgical risks and for fertility-sparing treatment in premenopausal patients; (3) adjuvant therapy for women with early-stage carcinosarcoma. A proposal was made that a GCIG Early Phase Consortium be developed to serve as an international platform for rapid assessment of biomarkers.

KW - Clinical trials planning meeting

KW - Endometrial cancer

KW - Gynecological Cancer Intergroup

KW - International collaboration

KW - Randomised trials

UR - http://www.scopus.com/inward/record.url?scp=84888266600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888266600&partnerID=8YFLogxK

U2 - 10.1097/IGC.0b013e3182a26edb

DO - 10.1097/IGC.0b013e3182a26edb

M3 - Article

C2 - 24257568

AN - SCOPUS:84888266600

VL - 23

SP - 1528

EP - 1534

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 8

ER -